Compare GPMT & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPMT | BDSX |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Precision Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.9M | 101.7M |
| IPO Year | N/A | 2020 |
| Metric | GPMT | BDSX |
|---|---|---|
| Price | $1.76 | $15.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $3.00 | ★ $32.50 |
| AVG Volume (30 Days) | ★ 234.4K | 118.5K |
| Earning Date | 01-01-0001 | 05-21-2026 |
| Dividend Yield | ★ 11.36% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $88,499,000.00 |
| Revenue This Year | $543.95 | $22.01 |
| Revenue Next Year | $33.91 | $26.81 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 24.08 |
| 52 Week Low | $1.61 | $0.25 |
| 52 Week High | $3.12 | $14.17 |
| Indicator | GPMT | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 35.34 | 74.96 |
| Support Level | $1.64 | $6.33 |
| Resistance Level | $2.71 | N/A |
| Average True Range (ATR) | 0.10 | 1.55 |
| MACD | -0.01 | 0.25 |
| Stochastic Oscillator | 16.91 | 73.52 |
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.